Phase I-II study: triciribine (tricyclic nucleoside phosphate) for metastatic breast cancer

Overview of attention for article published in Cancer Chemotherapy and Pharmacology, May 1995

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (71st percentile)
Good Attention Score compared to outputs of the same age and source (66th percentile)

So far, Altmetric has seen 21 patents that reference this research output.

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity, including 17 additional patents.